Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mapping diabetic sensory neuropathy by current perception threshold testing.

M S Rendell1, D J Dovgan, T F Bergman

  • 1Creighton Diabetes Center, Omaha, Nebraska 68131.

Diabetes Care
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia.

Diabetes, obesity & metabolism·2009
Same author

Comparison between nerve conduction studies and current perception threshold test in carpal tunnel syndrome [Neurophysiol Clin 38 (2008) 127-131].

Neurophysiologie clinique = Clinical neurophysiology·2008
Same author

Post pressure hyperemia in the rat.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2004
Same author

A comparison of the microvascular response in the healing wound in the spontaneously hypertensive and non-hypertensive rat.

International journal of surgical investigation·2003
Same author

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

The American journal of medicine·2001
Same author

Pharmacotherapy of type 2 diabetes mellitus.

The Annals of pharmacotherapy·2000

Current perception threshold (CPT) testing effectively assesses diabetic sensory neuropathy by measuring nerve function. This method shows higher CPTs in diabetic patients, indicating potential nerve damage.

Area of Science:

  • Neurology
  • Diabetology
  • Sensory Neuroscience

Background:

  • Diabetic sensory neuropathy is a common complication affecting nerve function.
  • Accurate assessment of neuropathy is crucial for patient management and treatment.
  • Existing methods may have limitations in sensitivity or specificity.

Purpose of the Study:

  • To evaluate the utility of Current Perception Threshold (CPT) testing for assessing diabetic sensory neuropathy.
  • To compare CPT results between diabetic subjects and nondiabetic volunteers.
  • To correlate CPT findings with clinical neurological examination scores.

Main Methods:

  • Clinical neurological examinations assessing sensory symptoms and physical signs were performed.
  • Standardized sensory testing (light touch, pain, vibration, thermal) was conducted at multiple anatomic sites.

Related Experiment Videos

  • Current Perception Threshold (CPT) testing using constant sine-wave-alternating current was applied at the same sites.

    • Main Results:

    • CPT showed moderate to strong correlations with physical examination scores (r = 0.55–0.62) and weaker correlations with symptom scores (r = 0.45–0.51).
    • Numbness showed the strongest correlation with CPT (r = 0.53), while pain and paresthesia correlations were lower.
    • Diabetic subjects generally exhibited higher CPTs than controls, but CPTs were normal in diabetics without clinical neuropathy.

    Conclusions:

    • CPT testing is a valuable tool for the objective assessment of diabetic sensory neuropathy.
    • CPT can differentiate between diabetic individuals with and without neuropathy.
    • This technique offers a reliable method to evaluate sensory nerve function in diabetes.